酸盐激酶M2 (PKM-2) 表达和预后意义在质母细胞瘤患者

Berrin Benli Yavuz1, Fahriye Kilinc2, Gul Kanyilmaz3

  • 1Department of Radiation Oncology, Meram Medical School, Necmettin Erbakan University, Konya, Turkey. berrinyavuz77@gmail.com.

Journal of neuro-oncology
|November 27, 2023
PubMed
概括

高酸盐激酶M2 (PKM2) 表达与接受放射治疗的质母细胞瘤患者的预后不佳有关. 这一发现表明PKM2可能是治疗质母细胞瘤的治疗点.